2m 2m 2m 2m 2m 2m 2m
Lyra Therapeutcs (LYRA)
OTC
$0.35+$0.34 (+3,380.00%)
Price as of Mar 16, 2026 7:59 PM EDT- $781,125.00Market Cap
- -99.87%1-Year Change
- BiotechnologyIndustry
Lyra Therapeutcs (LYRA)
$0.35+$0.34 (+3,380.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 40
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.01
$0.01
$0.01
1-Year Range
$0.0004
$8.09
$0.01
Latest Close$0.01
Change
+$0.010 (+96.00%)
Volume425
Market Cap$781,125.00
Shares Outstanding1.8M
P/E (TTM)-0.02
Diluted EPS (TTM)-$22.95
Enterprise Value-$21.3M
Information as of 08/21/2026
Company Profile
LYRA THERAPEUTICS INC
$781,125.00
Market Cap
-$32.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
LYRA THERAPEUTICS INC
Key Executives
- Vineeta Belanger
- Allison Nance
- Ronan O'Brien
- Elazer R. Edelman FACC
- Carmichael S. Roberts Jr.
Current Ownership Distribution
- Institutions367.4M (65.56%)
- Mutual Funds178.2M (31.80%)
- Insiders14.8M (2.65%)
- Other0 (0.00%)